This report provides preliminary estimates of Adoption and Foster Care Analysis and Reporting System (AFCARS) data for FY 2016. Since states are permitted to resubmit AFCARS data, the estimates may change over time. This report reflects all AFCARS data received as of October 20, 2017, related to AFCARS reporting periods through September 30, 2016.
The Centers for Disease Control and Prevention (CDC) has developed guidelines to improve prescribing opioids for chronic pain. Recommendations focus on the use of opioids in treating pain lasting longer than three months or past the time of normal tissue healing, outside of active cancer treatment, palliative care, and end-of-life care.
The Rx Awareness campaign tells the real stories of people whose lives were torn apart by prescription opioids. The goal of the campaign is to increase awareness that prescription opioids can be addictive and dangerous.
This report features key statistics and infographics from the latest data on increasing emergency department visits for suspected opioid overdoses. Includes actionable ideas and training for improving outcomes.
An in-depth analysis of 2016 U.S. drug overdose data shows that America’s overdose epidemic is spreading geographically and increasing across demographic groups.
As the incidence of opioid and heroin addiction grows, American law enforcement has developed new approaches to combating it. Based on collaborative partnerships with public health and other professionals, these new strategies stress prevention and treatment as well as enforcement. To identify the most effective of these approaches, the COPS Office hosted the Law Enforcement and Public Health: Successful Partnerships in Addressing Opioid Use Forum in partnership with the Office of National Drug Control Policy and the Police Executive Research Forum. Participants—who included representatives from public health agencies, law enforcement executives, and other stakeholders—discussed the establishment of treatment and prevention partnerships, the use of naloxone deployment programs, and best practices to mitigate drug use. They also discussed methods for sharing access to data and intelligence. This report not only documents the discussions but also describes innovative programs based on collaboration between the public health and public safety sectors.
This resource describes three post-overdose interventions that have shown promise in reducing the risk of subsequent overdoses and improving other health outcomes among people who have experienced a nonfatal overdose, highlighting the role of prevention practitioners in supporting these efforts.
Naloxone access laws make naloxone easier to obtain by expanding how the medication can be distributed beyond traditional prescriptions. This document describes the aims of naloxone access laws and the various forms they can take.
Toolkit for communities and local governments from the Substance Abuse and Mental Health Services Administration (SAMHSA) includes material to develop policies and practices to help prevent opioid-related overdoses and deaths.
This clinical guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The clinical guide helps health-care professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.
The U.S. Department of Agriculture (USDA) is approaching the opioid crisis with a dedicated urgency and is committed to being a strong partner to rural communities impacted by the issue. This webpage offers information about USDA resources and tools for addressing the opioid epidemic and includes an interactive community assessment tool, a rural resource guide, and links to state government resources.
This toolkit, developed by the HHS Center for Faith-Based and Neighborhood Partnerships, contains practical steps that your organization can take to bring hope and healing to people suffering from the consequences of opioid abuse disorder.
The Task Force, which was called for by the Comprehensive Addiction and Recovery Act of 2016, is assigned the following responsibilities:
The U.S. Department of State plays a key role within the U.S. whole-of-government effort to address the nation's opioid epidemic, aiming to stop illicit opioids from being produced overseas and trafficked into the United States. This webpage offers an overview of the agency's strategic work to stem the flow of opioids trafficked into the United States and ultimately save lives.
The DEA and Discovery Education have joined forces to combat a growing epidemic of prescription opioid misuse and heroin use nationwide. Operation Prevention’s mission is to educate students about the impacts of opioids and to kick-start lifesaving conversations in the home and classroom.
The National Drug Threat Assessment provides a yearly assessment of the many challenges local communities face related to drug abuse and drug trafficking. Highlights in the report include usage and trafficking trends for drugs such as prescription drugs, heroin, methamphetamine, cocaine, marijuana, and the hundreds of synthetic drugs.
The assessment factors in information from many data sources such as drug seizures, drug purity, laboratory analyses, information on the involvement of organized criminal groups, and survey data provided to DEA by 5,155 state and local law enforcement agencies across the country.